INTRODUCTION
The emergence of multi-drug-resistant strains of Mycobacterium tuberculosis and the increased incidence of tuberculosis have made it clear that there is an urgent need for new anti-tubercular agents [1] . In this regard, the mycobacterial cell-wall core, the mycolyl-arabinogalactan-peptidoglycan complex, which represents the site of action of many of the current first-line agents used to treat tuberculosis, represents a very attractive target for new anti-mycobacterial agents [2] . The cell wall also contains a variety of non-covalently bound lipids that are presumed to be necessary for cell viability and survival within the host [3] . Lipoarabinomannan (LAM) is one such component that belongs to the class of bacterial factors named modulins, and operates by inducing synthesis of host cytokines, including tumour necrosis factor-α (' TNF-α ') [4] . It also induces several early genes involved in macrophage activation [5] , and stimulates production of nitric oxide synergistically with interferon-γ (' IFN-γ ') [6] . M. tuberculosis LAM has also been shown to mediate phagocytosis of mycobacteria within phagocytic cells [7] . [Phosphatidyl-myo-inositol (PI)]mannosides (PIMs), known to be precursors of lipomannan (LM) and LAM, have recently been proposed to recruit natural killer (NK) T cells, which have a primary role in the granulomatous response [8, 9] . Moreover, a role for surfaceexposed PIMs as M. tuberculosis adhesins that mediate attachment to non-phagocytic cells has also been established [10, 11] .
Although the structure of LAM has been well documented [12] [13] [14] [15] , the genetics of the biosynthesis of this complex lipopolysaccharide remains a ' black box '. The recent availability of mycobacterial genome sequences [16] and the development of in itro assays have provided a means to study detailed enzyme function [17, 18] . The biosynthesis of LAM involves the addition of mannose (Man) residues to PI to produce both the short PIMs (2-5 Man residues) and LM, which is glycosylated further with arabinan to form LAM [12, 14, 19] . The biosynthetic relationship of PI PIMs LM LAM has recently been supported by biochemical [14, 18] and genetic studies [20] , but the details of this pathway remain highly speculative.
The biosynthesis of PIMs is initiated by distinct α-mannosyltransferase activities that utilize GDP-Man as a sugar donor, transferring initially a Manp (where p is pyranose) sugar residue to the 2-position of myo-inositol to form PI monomannoside (PIM " ), followed by a further addition to the 6-position of myoinositol to generate the dimannoside (PIM # ) [14, 18] . The latter GDP-Man-dependent α-mannosyltransferase has recently been shown to be catalysed by the pimB gene product from M. tuberculosis [20] . The addition of Manp residues to PIM # to form higher PIMs (PIM $ -PIM & ) also requires GDP-Man, according to the earlier studies of Brennan and Ballou [21] . Recently, using a cell-free assay and amphomycin, Besra et al. [18] demonstrated that triacylated-PIM # (Ac $ PIM # , according to the nomenclature of Gilleron et al. [9] , where ' Ac ' is ' acylated ') is specifically extended by the addition of Manp residues from the alkali-stable sugar donor, polyprenol-monophosphorylmannose (C $& \C &! -PMan), which is generated from GDP-Man and the corresponding C $& \C &! -polyprenol phosphate, to form higher PIMs (at least Ac $ PIM $ and Ac $ PIM % ) and linear LM possessing an α(1 6)-linked Manp backbone. The linear conformation of LM is then postulated to be mannosylated further, resulting in mature branched LM, which undergoes subsequent arabinosylation to form LAM.
PIMs, LM and LAM exist as discrete but heterogeneous populations with a Gaussian distribution that differ from each other in the extent and manner of mannosylation\arabino-sylation, acylation and other subtle modifications [22] . It is speculated that numerous α-mannosyltransferases are required for the formation of PIMs and LM, dictated by their chemically distinct precursors and utilization of different sugar donors
In the present study, we have undertaken the identification of a gene encoding a putative α-mannosyltransferase (RvD2-ORF1, where ' ORF ' is ' open reading frame ') found within M. tuberculosis CDC1551. We have assigned the function of this protein as being implicated in the biosynthesis of PIMs, and have addressed the precise question of its role in PIM synthesis by inactivating the analogous gene in Myobacterium bo is Bacille Calmette-Gue! rin (BCG).
MATERIALS AND METHODS

Bacterial strains and growth conditions
All cloning steps were performed in either Escherichia coli XL1-Blue (Stratagene, La Jolla, CA, U.S.A.) or E. coli TOP-10 (Invitrogen, Carlsbad, CA, U.S.A.). Mycobacterium smegmatis mc#155 is an electroporation-efficient mutant of M. smegmatis mc#6 [23] . Large-scale cultures of M. smegmatis were grown to mid-exponential phase (D '!! 0.6-0.7) in Luria-Bertani medium containing 0.05 % (v\v) Tween 80 in the presence or absence of 25 µg\ml kanamycin (Sigma, St Louis, MO, U.S.A.), harvested, washed with PBS, and then stored at k20 mC until further use. Disruption of RvD2-ORF1 was performed using the M. bo is BCG vaccine strain 1173P2 (World Health Organization, Stockholm, Sweden). M. bo is BCG strains were plated on to Middlebrook 7H10 agar containing oleic acid-albumin-dextrose-catalase enrichment (Difco, Detroit, MI, U.S.A.) and eventually supplemented with 50 µg\ml hygromycin (hyg) (Roche Molecular Biochemicals, Basel, Switzerland), whereas liquid cultures were grown at 37 mC in Sauton medium.
Plasmids and DNA manipulation
Plasmid pUC18 was purchased from New England Biolabs (Beverly, MA, U.S.A.). Expression of RvD2-ORF1 in mycobacteria was achieved using the E. coli-mycobacterial shuttle vector pMV261 containing the hsp60 promoter [24] . Genomic DNA from M. tuberculosis CDC1551 was obtained from J. Belisle (Department of Microbiology, Colorado State University, Fort Collins, CO, U.S.A.). The cosmid library pYUB328 described by Balasubramanian et al. [25] was generously provided by W. R. Jacobs (Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, NY, U.S.A.). The plasmid pUC-HY [26] was kindly provided by R. W. Stokes (Division of Infectious and Immunological Diseases, University of British Columbia, Vancouver, Canada). Restriction enzymes and T4 DNA ligase were purchased from Roche Molecular Biochemicals and Vent DNA polymerase was purchased from New England Biolabs. All DNA manipulations were performed using standard protocols, as described by Sambrook et al. [27] .
Bioinformatic methods
BLAST analysis was performed against the M. tuberculosis CDC1551 genome database at The Institute for Genomic Research (TIGR ; http :\\www.tigr.org). Putative α-mannosyltransferases from M. tuberculosis H37Rv were identified at http :\\ genolist.pasteur.fr\TubercuList\. The classification of glycosyltransferases is accessible at CAZy (http :\\afmb.cnrs-mrs.fr\ CAZY\), whereas Pfam glycosyltransferase 1 family (GT1F) can be accessed at www.sanger.ac.uk\Software\Pfam\. Multiple sequence alignments were performed using the Clustal Method of DNA Star.
Overexpression of RvD2-ORF1 in E. coli and M. smegmatis
RvD2-ORF1 from M. tuberculosis CDC1551 was cloned into the mycobacterial overexpression vector pMV261 as follows. PCR amplification was performed using the upstream primer M1 5h-GTG TTG TTC AGG TCG CAA ACT TCT ATG G-3h and the downstream primer M2 5h-GCA GGATCC GGC CGC AAA CTT-3h which contains a BamHI restriction site (underlined). The 1169 bp PCR product was then digested with BamHI and cloned into the MluNI\BamHI-restricted pMV261, giving rise to pMV261-RvD2-ORF1. For expression in E. coli, the bluntended PCR fragment was cloned into a pUC8 plasmid cut by SmaI. Coding sequence of RvD2-ORF1, as well as its junctions with either the hsp60 or the Plac promoter, were verified by DNA sequencing.
Mannosyltransferase assays
Membrane fractions prepared from M. smegmatis expressing recombinant RvD2-ORF1 were assayed and compared with membranes from M. smegmatis transformed with empty pMV261 for α-mannosyltransferase activity, using a method adapted from Besra et al. [18] . Reaction mixtures contained 500 µg of membranes (total protein), buffer A containing 0.1 mM dithiothreitol, 10 mM CaCl # and 2.5 µg of amphomycin (a lipopeptide antibiotic that specifically inhibits polyprenyl-P-requiring translocases and the synthesis of C $& \C &! -P-Man) in a total volume of 50 µl. Reactions were incubated for 10 min at 37 mC before the addition of 0.25 µCi of GDP-["%C]Man (303 mCi\mmol ; Amersham Biosciences, Uppsala, Sweden), and held at 37 mC for a further 30 min. The reactions were stopped by the addition of 4 ml of trichloromethane\methanol\water (10 : 10 : 3, by vol.) and incubated at room temperature for 30 min, followed by the addition of 1.75 ml of trichloromethane and 0.75 ml of water. The lower organic layer of the biphasic mixture was washed three times with 2 ml of trichloromethane\methanol\water (3 : scintillation counting, and the material was analysed by TLC autoradiography, as described previously [20] .
Analysis of reaction products
Large-scale reaction mixtures containing unlabelled GDP-Man (80 mM) and the other components were prepared and processed as described above. The reaction products were dried, applied to preparative TLC plates in addition to radiolabelled material (50 000 c.p.m.) to trace the cold enzymically synthesized products, and developed in trichloromethane\methanol\ammonium hydroxide\water (65 : 25 : 0.5 : 3.6, by vol.). Autoradiography was performed by exposing the TLC to X-ray film (Kodak X-Omat, Rochester, NY) for 24 h. The band corresponding to the new enzymically synthesized PIM product was recovered from the plates using 4 ml of trichloromethane\methanol\water (10 : 10 : 3, by vol.) at room temperature for 30 min, followed by the addition of 1.75 ml of trichloromethane and 0.75 ml of water. The lower organic layer of the biphasic mixture was washed three times with 2 ml of trichloromethane\methanol\water (3 : 47 : 48, by vol.), dried under a stream of nitrogen and per-O-acetylated before fast-atom-bombardment (FAB) MS analysis.
Chemical derivative-formation for FAB-MS analysis
The PIM product synthesized by RvD2-ORF1 was per-Oacetylated using 100 µl of pyridine\acetic anhydride (1 : 1, v\v) at 80 mC for 2 h, after which the reagents were removed under a stream of nitrogen and the samples were extracted into trichloromethane and washed several times with water, before drying under a stream of nitrogen. FAB-MS spectra were acquired in the positive-ion mode using a ZAB-2SE 2FPD mass spectrometer fitted with a caesium ion gun operated at 30 kV. Data acquisition and processing were performed using VG Analytical Opus software [28] .
Screening of the M. bovis BCG genomic DNA library
The pYUB328 cosmid DNA library of M. bo is BCG [25] was used to transform E. coli XL1-Blue and screening was performed by colony-blot hybridization using RvD2-ORF1 as a probe. The RvD2-ORF1 probe corresponding to the entire RvD2-ORF1 sequence was labelled with digoxigenin (DIG)-dUTP5h using the PCR DIG Probe Synthesis Kit (Roche Molecular Biochemicals) with oligonucleotides M1 and M2. Pre-hybridization and hybridization were performed at 42 mC and 50 mC respectively, using the DIG Easy Hyb buffer (Roche Molecular Biochemicals). Posthybridization washes were performed twice in 2iSSC (where 1iSSC is 0.15 M NaCl\0.015 M sodium citrate)\0.1 % (w\v) SDS for 5 min at room temperature, and twice in 0.1iSSC, 0.1 % SDS for 15 min at 68 mC. The hybridized probe was detected using a DIG luminescence detection kit (Roche Molecular Biochemicals) according to the manufacturer's recommendations. Approx. 400 individual clones were screened and five positive clones were obtained. Cosmid DNA was prepared and analysed further by restriction digests and Southern-blot hybridization using the RvD2-ORF1 probe. A 10.5 kb BamHI restriction fragment bearing the RvD2-ORF1 was subcloned from one of these cosmids into pUC18, creating pUC18-10.5.
Construction of a suicide vector for RvD2-ORF1 gene disruption
Plasmid pUC18-10.5 was examined for restriction sites, which could facilitate RvD2-ORF1 disruption. A unique SfuI restriction site was found within RvD2-ORF1, and used for subsequent cloning of a hyg-resistance cassette, which was obtained by PCR amplification. PCR was performed using pUC-HY and the following primers : sense primer, hyg1 5h-ACC AAG CCC TCG GCG ACG TTC C-3h, and antisense primer, hyg2 5h-GAG GAT CCC CGG GTA CCG CCG TC-3h. The suicide vector designated pKO-RvD2-ORF1 contained 3.5-kb-and 7-kb-homologous mycobacterial DNA segments flanking the hyg cassette. The plasmid genotype was confirmed by restriction analysis and PCR amplification.
Transformation of M. bovis BCG with pKO-RvD2-ORF1, and the screening of transformants
Construct pKO-RvD2-ORF1 was linearized with HindIII and electroporated in M. bo is BCG-competent cells, as described previously [29] . Transformant colonies growing on Middlebrook 7H10 with 50 µg\ml hyg were screened by PCR using primers M3 (5h-CGC GCA CCG AAC GAC ACC TCC TAC-3h) and M4 (5h-GCC GCC GCG GGT GGA AGG TCT T-3h), as described by Flesselles et al. [30] .
Genomic DNA preparation and Southern-blot hybridization
Genomic DNA from M. bo is BCG cultures was prepared as follows. -Cycloserine (25 µg ; Sigma) was added to a 10 ml saturated culture of M. bo is BCG, which was then incubated overnight at 37 mC. Cells were then pelleted and re-suspended in 250 µl of solution I [25 % sucrose\50 mM Tris\HCl (pH 8.0)\ 50 mM EDTA\500 µg\ml lysozyme] and incubated for 4 h at 37 mC. Solution II [100 mM Tris\HCl (pH 8.0)\1 % (w\v) SDS\400 µg\ml proteinase K] was added (250 µl), and the mixture was incubated for 3 h at 55 mC. The lysate was then extracted three times with phenol\chloroform\3-methylbutan-1-ol (25 : 24 : 1, by vol.), and DNA was concentrated by ethanol precipitation. Approx. 2 µg of genomic DNA was digested overnight with an excess of restriction enzyme (PstI or Asp718). The fragments were then separated by electrophoresis using a 0.7 % (w\v) agarose gel and transferred on to a positively charged nylon membrane (Roche Molecular Biochemicals). DNA was then UV-cross-linked using a Stratalinker apparatus (Stratagene) incubated in DIG Easy Hyb buffer for pre-hybridization, and finally hybridized with different probes using the same conditions as for colony-blot hybridization. Detection was performed using the DIG luminescence detection kit (Roche Molecular Biochemicals), according to the manufacturer's recommendations.
Southern-blot hybridization analysis of clinical isolates was performed according to the standard protocol used for molecular fingerprinting [31] . Briefly, DNA from clinical isolates was digested with P uII and electrophoresed on 1 % (w\v) agarose gels. The products were transferred to nylon membranes, hybridized with a non-radioactively labelled IS6110 probe, and then subsequently with the RvD2-ORF1 probe. Detection was performed according to the standard protocol using the enhanced chemiluminescence direct nucleic acid labelling and detection kit (Amersham Biosciences) [31] .
Biochemical analysis of PIM, LM and LAM from both M. bovis BCG and the M. bovis BCG-disrupted RvD2-ORF1 mutant
Extraction and analysis of PIMs was performed as described by Besra [32] . Briefly, M. bo is BCG cultures were labelled by adding 1 µCi\ml [1,2-"%C]acetate (50-62 mCi\mmol ; Amersham Biosciences) and the "%C-labelled cells were harvested by centrifugation and washed with PBS. The bacterial pellet was extracted using 2 ml of methanol\0.3 % (w\v) NaCl (100 : 10, v\v) and 1 ml of petroleum ether. Following centrifugation, the upper petroleum ether layer was removed, and the polar lipids were extracted further from the residue. The methanolic-saline fraction was heated at 65 mC for 5 min and mixed with 2.3 ml of trichloromethane\methanol\0.3 % NaCl (9 : 10 : 3, by vol.). After centrifugation, the supernatant was retained and the residue was extracted further by adding 0.75 ml of trichloromethane\ methanol\0.3 % NaCl (5 : 10 : 4, by vol.). The solvent extracts were then combined with 1.3 ml of trichloromethane and 1.3 ml of 0.3 % NaCl. The lower organic phase obtained after centrifugation was evaporated to dryness and the polar lipids were resuspended in trichloromethane\methanol\water (10 : 10 : 3, by vol.). Equal amounts of material (50 000 c.p.m.) were loaded on to silica gel plates (5735 silica gel 60F #&% ; Merck, Darmstadt, Germany). Two-dimensional TLC was performed using trichloromethane\methanol\water (60 : 30 : 6, by vol.) in the first dimension, and trichloromethane\acetic acid\methanol\water (40 : 25 : 3 : 6, by vol.) in the second dimension. Autoradiograms were produced by exposure to Kodak X-Omat AR film after 4-5 days to reveal "%C-labelled PIMs. LM and LAM were extracted as described previously [32] , and analysed by SDS\PAGE using silver\periodic acid staining.
RESULTS
Identification of RvD2-ORF1 in M. tuberculosis CDC1551 as a putative α-mannosyltransferase
Schaeffer et al. [20] recently identified M. tuberculosis H37Rv pimB, which encoded an α-mannosyltransferase involved in the formation of Ac $ PIM # from GDP-Man and Ac $ PIM " . BLAST analysis of the M. tuberculosis CDC1551 genome sequence database at TIGR has revealed the presence of several proteins
Figure 1 Alignment of RvD2-ORF1 with other putative α-mannosyltransferases identified in the genome of M. tuberculosis H37Rv
The alignment was generated using the Clustal algorithm of MegAlign (DNAStar). Identical amino acids are highlighted in reversed-out lettering on a black background, and similar residues are highlighted in grey. The last entry is the pFam consensus proposed for the GT1F family. The boxed consensus sequence delineates the conserved EX 7 with similarity to PimB (Rv0557) (Figure 1) . One of these, annotated as RvD2-ORF1 as described by Gordon et al. [33] , or MT1800 according to TIGR, shares 33 % identity with PimB. RvD2-ORF1 (accession number AAK46 073) encodes a putative α-glycosyltransferase found in Family 4 [34] of the CAZy classification of glycosyltransferases (http :\\afmb.cnrs-mrs.fr\ CAZY\) and in glycosyltransferase 1 family (GT1F) in the Pfam database [34, 35] . CAZy Family 4 consists of more than 300 proteins, whereas Pfam GT1F contains 397 proteins, including members of CAZy Family 4. RvD2-ORF1 and PimB, as well as six other putative α-mannosyltransferases found in the M. tuberculosis H37Rv, contain the conserved EX ( E motif (GluXaa ( -Glu ; amino acids 283-291). This motif is thought to be associated with the retention of C1 configuration in various retaining glycosyltransferases [36] , such as the CAZy Family 4 α-mannosyltransferase AceA from Acetobacter xylinum [37] . It has also been suggested that the EX ( E motif from AceA is involved in sugar-nucleotide binding [37] . In addition, the sequence alignments presented in Figure 1 show the presence of a conserved lysine residue (Lys#"#), which is present in all CAZy Family 4 glycosyltransferases [34, 36] . Replacement of Lys#"" with alanine in AceA results in a complete loss of activity, which suggests a possible role in binding of the diphosphate group of the sugar donor, GDP-Man [37] . Other significant conserved residues include Gly"(&, Asp"(( and Arg#!(, which are highlighted in Figure 1 , although no function has been assigned to these residues. Thus the similarity between RvD2-ORF1 and PimB with other retaining CAZy Family 4 glycosyltransferases suggests that RvD2-ORF1 is presumably a GDP-Man-dependent α-mannosyltransferase involved in PIM biosynthesis.
We therefore conducted a study first to determine whether RvD2-ORF1 encodes an α-mannosyltransferase involved in PIM biosynthesis, and secondly, to examine the consequence of 
Evidence that RvD2-ORF1 catalyses the formation of triacylated-PIM 3
RvD2-ORF1 was first cloned into several expression vectors and transformed into E. coli. Overexpression of the gene in E. coli led to the production of a new protein ; however, the observed level of expression was lower than normally obtained with these expression systems, and all of the recombinant protein was found in the cell-debris fraction (27 000 g pellet) of cell homogenates (results not shown). In addition, no enzymic activity was detected in the soluble cytosolic portion (100 000 g supernatant) or the membrane (100 000 g pellet) of the cell homogenates (results not shown). Therefore expression studies were conducted in M. smegmatis by cloning the gene into pMV261, which drives expression from a native mycobacterial hsp60 promoter.
M. smegmatis transformed either with pMV261-RvD2-ORF1 or pMV261 were examined for GDP-Man-dependent α-mannosyltransferase activities associated with PIM biosynthesis using a cell-free assay [18, 20] . Cell-free assays performed with membranes prepared from cells transformed with empty pMV261 produced only Ac Further TLC-autoradiographic analysis revealed that overexpression of RvD2-ORF1 influenced directly the in itro PIM profile of M. smegmatis (Figure 2 ). In comparison with assays performed with membranes prepared from cells transformed with pMV261, membranes prepared from cells transformed with pMV261-RvD2-ORF1 revealed a new product, which was
Figure 4 Inactivation of pimC in M. bovis BCG
(A) The strategy used to inactivate pimC in M. bovis BCG. A M. bovis BCG cosmid designated PimC5.2 was first isolated from a M. bovis BCG cosmid library. A Bam HI 10.5 kb fragment containing the entire pimC sequence was isolated from cosmid PimC5.2 and subcloned into pUC18. The pimC was then interrupted by cloning a hyg-resistance cassette within the unique SfuI restriction site. This suicide vector, pKO-pimC, was linearized with Hin dIII and subsequently used to transform M. bovis BCG. Arrows indicate the position of the two primers M3 and M4 used for PCR screening. A, Asp718 ; B, Bam HI ; P, Pst I; S, Sfu I; H, Hin dIII ; bla, β-lactamase ; hyg, hyg-resistance cassette. (B) Genomic DNA was prepared from WT M. bovis BCG, and from six individual M. bovis BCG clones that showed a disrupted genotype by PCR screening on colonies (BCG-KO.27 to BCG-KO.99). The first lane contains no DNA, as a negative control of PCR, whereas pKO-pimC (third lane) was added as a positive control. As expected, WT M. bovis BCG generated a 0.43 kb fragment, that was increased further by 1.6 kb (corresponding to the hyg cassette) for pKO-pimC, as well as for the six mutants. (C) Southern-blot hybridization was performed on pKO-pimC and on genomic DNA prepared from both WT M. bovis BCG and BCG-KO. 27 . DNA was restricted with either Asp718 or Pst I, and probed with either pimC (left panels) or hyg (right panels). M, DIG-labelled molecular-mass markers.
tentatively assigned as Ac $ PIM $ , on the basis of its relative retardation factor and our previous studies in relation to PimB and the identification of Ac $ PIM " \Ac $ PIM # [20] . The synthesis of Ac $ PIM " and Ac $ PIM # was slightly diminished in assays performed with membranes prepared from cells transformed with pMV261-RvD2-ORF1 in comparison with pMV261 ( Figure 2) . The fact that Ac $ PIM $ cannot be isolated from membrane preparations of untransformed M. smegmatis may be explained by either the absence of the pimC gene in this mycobacterial species, or by a low expression level of PimC. On the other hand, Ac $ PIM $ may be produced transiently due to a very rapid turnover. A BLAST search in the M. smegmatis genome database revealed the absence of the pimC gene (results not shown).
It was originally envisaged that RvD2-ORF1 would be involved in the synthesis of Ac $ PIM " via a GDP-Man-dependent α-mannosyltransferase (PimA) to PI, followed by a subsequent acyltransferase. As a consequence, the expected TLC phenotype would have presumably been an increase in the synthesis of Figure 3 (B), with a total of three fatty acyl chains (two C "' : ! , one C "* : ! ) and three hexose residues. The signal at m\z 2167 [MkHj2Na] + carries an additional sodium atom. In addition, informative fragment ions from the low-mass region of the FAB-MS spectrum (results not shown) are shown schematically in Figure 3(B 
Disruption of pimC by allelic exchange in M. bovis BCG
To establish further whether pimC encodes an α-mannosyltransferase involved in the biosynthesis of Ac $ PIM $ , presumably from the Ac $ PIM # precursor (the metabolic product of PimB [20] ), the gene was disrupted in M. bo is BCG. To achieve allelic exchange, pKO-pimC was constructed, which contained a 10.5 kb BamHI 14 C-labelled PIMs were revealed by exposure to a Kodak X-Omat AR film after 4-5 days. The nomenclature (Ac 3 PIM 2 , etc.) is on the basis of the recent identification of the PIM family from M. bovis BCG by Gilleron et al. [9] using electrosprayionization MS.
fragment of homologous DNA, including pimC ( Figure 4A ). In this DNA segment, pimC was interrupted with a hyg-resistance cassette. Using this suicide vector, allelic exchange is only possible by homologous recombination via a double crossover, which would insert the disrupted pimC into the mycobacterial chromosome. A hundred hyg-resistant M. bo is BCG transformants generated by electroporation of pKO-pimC were screened by PCR to amplify both sides of the inserted hyg gene. Six transformants, designated BCG-KO.27, BCG-KO.45, BCG-KO.53, BCG-KO.55, BCG-KO.90 and BCG-KO.99, yielded a 2 kb PCR product, as expected from homologous recombination via a double crossover. The wild-type (WT) product, indicative of spontaneous hyg-resistant clones, resulted in a 0.43 kb fragment. PCR amplification of WT M. bo is BCG and six transformants that had undergone allelic replacement were confirmed using purified genomic DNA from each strain ( Figure 4B ). To confirm the results of the PCR screen, the putative mutants were examined by Southern-blot hybridization for the presence of the mutated pimC allele using two different probes ( Figure 4C ). When pimC was used as a probe, digestion of genomic DNA from BCG-KO.27 with Asp718 resulted in an increase in size over the 3.8 kb parental fragment length and the presence of an additional band of 0.98 kb. When digested with PstI, DNA from WT M. bo is BCG showed a single band of 2.5 kb, which was increased in size by 1.6 kb corresponding to the size of the hyg gene. As expected, no signal was observed when hyg was used to probe DNA from WT M. bo is BCG, regardless of the restriction enzyme used. However, single bands of the expected size confirmed again the disruption of pimC by allelic exchange. Identical restriction patterns were obtained for the other five pimCinactivated M. bo is BCG clones (results not shown).
Characterization of the M. bovis BCG disrupted pimC strain
Analysis of PIM distribution in the M. bo is BCG and pimC mutant M. bo is BCG strains was achieved by labelling cells using ["%C]acetate, extracting the labelled PIMs and then resolving the different PIM species by two-dimensional TLC. As shown in Figure 5 , no change in the PIM profile was observed in the mutant strain compared with the WT strain. Moreover, the mutant strain was still able to produce LM and LAM in similar proportions when compared with the WT M. bo is BCG strain (results not shown). Our earlier homology-based searches for GDP-Man-dependent α-mannosyltransferases centred around PimB, supported by the above biochemical findings, do suggest that PimC is involved in synthesis of Ac $ PIM $ . However, the results with the pimC-disrupted M. bo is BCG mutant suggest that additional α-mannosyltransferase(s) may be responsible for the synthesis of Ac $ PIM $ , implying the existence of compensatory gene(s) or an alternate pathway in the genome of M. bo is BCG and M. tuberculosis CDC1551 (see below), presumably using the C $& \C &! -P-Man sugar donor and Ac $ PIM # , as suggested in our earlier studies in itro ( [18] ; see Scheme 1).
Genetic distribution of pimC among M. tuberculosis clinical isolates
A comparative genomic analysis of M. tuberculosis CDC1551, M. tuberculosis H37Rv and M. bo is BCG revealed that pimC corresponds to ORF1 of the RvD2 deletion of the published H37Rv sequence [16, 33] . A recent study aimed at identifying attenuation mutations in M. tuberculosis H37Ra has shown that the RvD2 locus was present in the M. tuberculosis H37Ra substrain, but not in M. tuberculosis H37Rv [38] . The M. tuberculosis H37Ra RvD2 locus contains three ORFs, with two flanking IS6110 elements. The observation that the RvD2 deletion in M. tuberculosis H37Rv contains a copy of IS6110 lacking direct repeats that flank the ends of the element indicates that this deletion was probably due to an IS6110-mediated mechanism, characterized by recombination between insertion sequences (' ISs '), with loss of the region between the elements. Gordon et al. [33] have also analysed the distribution of the RvD2 deletion among the M. tuberculosis complex, as well as in seven different M. tuberculosis clinical isolates. In order to extend this study, we have analysed by Southern blotting the distribution of pimC in over 80 representative M. tuberculosis clinical isolates ( Figure 6 ). All clinical isolates were characterized previously by IS6110 fingerprinting, and represent both clustered and unique isolates from a population-based study in the state of New Jersey [39] . Overall, pimC was found to be present in 22 % (17\80) of the
Scheme 1 Postulated pathways for the biosynthesis of the PIMs, LM and LAM in M. tuberculosis
Figure 6 Genetic distribution of pimC in various M. tuberculosis clinical strains
Southern-blot hybridization of representative clinical isolates from a population-based study [39] . Hybridization was first performed using a IS6110 probe (A), and then the pimC probe (B), according to standard protocols [31] . The IS6110 pattern diversity revealed in (A) corresponds to the different M. tuberculosis isolates analysed. Only two strains (lanes 4 and 11) were found to contain the pimC insert, as depicted by rectangles in (A). Each lane depicts a different clinical isolate, whereas M indicates the DNA molecular marker.
isolates analysed. In addition, the RvD2 locus was found to be present in only two of the large clusters investigated, primarily in isolates known as the ' Harlem ' family [40] , which includes the Erdman strain and the multi-drug-resistant ' P ' cluster from New York City [41] (results not shown).
DISCUSSION
The specific number of α-mannosyltransferases that are involved in PIM, LM and LAM biosynthesis is a matter of speculation, depending on how the α(1 6)-linked mannan backbone and α(1 2)-Man side chains are assembled. One can speculate that numerous enzymes may be required for the formation of various linkages. In addition, different acceptor and donor specificities may be necessary at some stages, and there is a possibility that certain Man residues may be added sequentially, whereas others may come from intermediates accumulated on lipid carriers [18] . In addition, there may be species-specific enzyme requirements beyond the structurally conserved PIMs, LM and LAMs. For instance, enzymes that are involved in Man-capping of LAM will differ from those that are necessary to build its mannan core [42] . Indeed, BLAST analysis of the M. tuberculosis H37Rv genome sequence database shows similarity between PimC and various predicted proteins. For instance, PimB (Rv0557) and also Rv0225, Rv0486, Rv1212c, Rv2188c, Rv2610c and Rv3032 all contain the EX ( E motif. The similarity of these predicted gene products to PimC suggests that they may also be α-mannosyltransferases involved in the biosynthesis of PIM, LM and LAM, although the EX ( E motif is present in a number of bacterial glycosyltransferases other than α-mannosyltransferases [36] . Further analysis of PimC predicts two transmembrane regions from amino acids 265-285 and 354-372, suggesting that PimC may be a membrane or a membrane-associated protein. This is consistent with the observed localization of GDP-Man-dependent α-mannosyltransferases in mycobacteria [18] . However, it is worth noting that hydrophobic helices may be buried into a globular structure, and that glycosyltransferases may be associated to membranes by different mechanisms [43, 44] .
Overexpression of pimC from M. tuberculosis CDC1551 in M. smegmatis led to an overall enhanced α-mannosyltransferase activity associated with PIMs. Qualitative analysis by TLC autoradiography of the reaction products shows an accumulation of a new PIM member migrating with a lower retardation factor than Ac $ PIM # . The structural characterization of this product by FAB MS established that the compound was Ac $ PIM $ . As discussed, the overexpression of PimC would catalyse the transfer of Manp from GDP-Man to Ac This hypothesis is strengthened by the fact that pimC was originally isolated and cloned from M. tuberculosis CDC1551, and was absent from M. tuberculosis H37Rv [16] , a strain producing PIMs, LM and LAM. Comparative genomics has recently revealed that M. tuberculosis H37Rv contains two deletions, RvD1 and RvD2, relative to the other members of the complex [33] . The RvD2 region was found to be present in M. africanum, M. bo is, M. bo is BCG, M. microti OV254 and M. tuberculosis CDC1551 [33] , as well as in the attenuated M. tuberculosis H37Ra [38] . The RvD2 deletion locus contains three ORFs, designated RvD2-ORF1, RvD2-ORF2 and RvD2-ORF3, with two flanking IS6110 elements interrupted by two further ORFs [38] . We have extended this study by analysing the genetic distribution of pimC (formerly RvD2-ORF1) in over 80 clinical M. tuberculosis isolates characterized previously by IS6110 fingerprinting [39] , and found that the gene was present in only 22 % of the isolates. This observation is in agreement with other reported investigations [46] , which identify the RvD2 locus to be within a highly variable region of the chromosome. Analysis of 24 isolates revealed extensive genetic diversity, including 14 variants characterized by IS6110 insertion and deletion events resulting from probable homologous recombination [46] . Alterations to this locus were also found within at least some of the H37Rv progenies of the laboratory strain H37Rv\Ra [38, 46] . Searches in the mycobacterial genome databases also revealed the presence of pimC in M. a ium, and the absence of this gene in M. leprae and M. smegmatis (results not shown).
The possible redundancy of genes that are involved in mycobacterial cell-wall biosynthesis seems not to be an uncommon issue in M. tuberculosis. It has been shown that the dominant exported proteins of M. tuberculosis (called the antigen 85 complex) consisting of Ag85A, Ag85B and Ag85C, are highly related gene products that all display mycolyltransferase activity involved in the final stages of mycobacterial cell-wall assembly [47] . The importance of the 85 antigen proteins was highlighted through an analysis of a mutant strain deficient in Ag85C. The Ag85C mutant possessed 40 % less mycolic acids in the cell wall compared with WT bacilli [48] . Since mycolyltransferase activity was not completely abrogated in the Ag85C knock-out strain, it has been suggested that the other members of the complex may compensate, at least partially, the loss of mycolic acids in the cell wall. The possibility of redundancy is further supported by our own recent studies, which demonstrated that the GDP-Mandependent α-mannosyltransferase involved in the synthesis of Ac $ PIM # catalysed by PimB [20] is also a dispensable gene, suggesting that other putative GDP-Man-dependent α-mannosyltransferases within the M. tuberculosis genome may compensate for this loss in i o (L. DesJardin, G.S. Besra and L. Schlesinger, unpublished work).
An increasing body of evidence has shown that LAM has a key role in the pathogenesis of mycobacterial diseases, so agents that disrupt its biosynthesis will undoubtedly affect the ability of M. tuberculosis to survive within the host. Drugs that specifically inhibit unique steps involved in PIM biosynthesis will also affect the ability of the organism to produce LM and LAM, thus altering cell wall structure and integrity. Therefore α-mannosyltransferases that are involved in the biosynthesis of PIM and LM are prospective targets for the design of novel chemotherapeutic agents against pathogenic mycobacteria. The present report demonstrates that pimC is a dispensable gene due to the presence of compensatory mechanisms, and therefore does not represent an attractive target for the development of new anti-mycobacterial agents. However, it does shed valuable information on understanding the biochemical and molecular basis of PIM, LM and LAM biosynthesis in the genomics era, and will hopefully lead to the further development of the PIM-biosynthetic pathway in terms of the identification of other α-mannosyltransferases that are utilized in the subsequent addition of Manp residues to form PIMs, and ultimately LM and LAM.
Finally, the availability of the recombinant M. smegmatis strain overexpressing PimC now allows us to produce and purify Ac $ PIM $ , a glycolipid undetectable in crude mycobacterial lysates. This will be particularly useful in investigating the biological functions associated with Ac $ PIM $ , such as its capacity to mediate attachment to cells [10, 11] , to recruit NK T cells or to participate in the granulomatous response [8, 9] .
